India - English - Central Drugs Standard Control Organization

geno ph. - beta carotene,vit.a,vit.e,vit.c,zinc sulph.,selenium dioxide - cap - 33mg,2500iu.(palmitate),10iu(acet.),50mg,27.45mg,70mcg - 10

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

soho flordis international switzerland sa - beta carotene, vitamin b1, vitamin b2, vitamin b6, vitamin b12, vitamin c, vitamin d3, vitamin e, folic acid, biotin, nicotinamide, chromium (chromium chloride), copper (copper sulfate), iron (ferrous fumarate), iodine (potassium iodide), molybdenum (sodium molybdate dihydrate), selenium (sodium selenite), zinc (zinc oxide), magnesium, calcium - tablets film-coated - 2mg+ 1,4mg+ 1,4mg+ 1,9mg+ 2,6mcg+ 85mg+ 200iu (5mcg)+ 15mg+ 600mcg+ 30mcg+ 18mg+ 30mcg+ 1mg+ 27mg+ 200mcg+ 50mcg+ 60mcg+ 11mg+ 53mg+ 150mg

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

ginsana sa - beta carotene, vitamin b1, vitamin b2, vitamin b6, vitamin b12, vitamin c, vitamin d3, vitamin e, folic acid, biotin, nicotinamide, chromium (chromium chloride), copper (copper sulfate), iron (ferrous fumarate), iodine (potassium iodide), molybdenum (sodium molybdate dihydrate), selenium (sodium selenite), zinc (zinc oxide), magnesium, calcium - tablets film-coated - 2mg+ 1.4mg+ 1.4mg+ 1.9mg+ 2.6mcg+ 85mg+ 200iu (5mcg)+ 15mg+ 600mcg+ 30mcg+ 18mg+ 30mcg+ 1mg+ 27mg+ 200mcg+ 50mcg+ 60mcg+ 11mg+

India - English - Central Drugs Standard Control Organization

gsk - beta carotene,vit.e,vit.c,selenium dioxide,zinc sulph. - cap - 10mg(30% dispersion),25mg,150mg,75mcg,61.8mg - 30

United States - English - NLM (National Library of Medicine)

actavis pharma, inc. - betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - betamethasone 0.5 mg in 1 g - betamethasone dipropionate cream is a medium-potency corticosteroid indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13 years and older. betamethasone dipropionate cream is contraindicated in patients who are hypersensitive to betamethasone dipropionate, to other corticosteroids, or to any ingredient in this preparation.

United States - English - NLM (National Library of Medicine)

preferred pharmaceuticals, inc - betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - betamethasone 0.5 mg in 1 g - betamethasone dipropionate ointment is a high-potency corticosteroid indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13 years and older. betamethasone dipropionate ointment is contraindicated in patients who are hypersensitive to betamethasone dipropionate, to other corticosteroids, or to any ingredient in these preparations.

United States - English - NLM (National Library of Medicine)

actavis pharma, inc. - betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - betamethasone 0.5 mg in 1 g - betamethasone dipropionate ointment is a high-potency corticosteroid indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13 years and older. betamethasone dipropionate ointment is contraindicated in patients who are hypersensitive to betamethasone dipropionate, to other corticosteroids, or to any ingredient in these preparations.

United States - English - NLM (National Library of Medicine)

taro pharmaceuticals u.s.a., inc. - betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - betamethasone dipropionate 0.64 mg in 1 g - betamethasone dipropionate cream is a medium-potency corticosteroid indicated for relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses in patients 13 years and older. betamethasone dipropionate cream is contraindicated in patients who are hypersensitive to betamethasone dipropionate, to other corticosteroids, or to any ingredient in this preparation.

United States - English - NLM (National Library of Medicine)

e. fougera & co. a division of fougera pharmaceuticals inc. - betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - betamethasone .50 mg in 1 g - betamethasone dipropionate gel (augmented) is a super-high potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. treatment beyond two consecutive weeks is not recommended, and the total dose should not exceed 50 g per week because of potential for the drug to suppress the hypothalamic-pituitary-adrenal (hpa) axis. this product is not recommended for use in pediatric patients under 12 years of age. betamethasone dipropionate gel (augmented) is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

United States - English - NLM (National Library of Medicine)

rebel distributors corp. - betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - betamethasone dipropionate 0.05 mg in 1 g - betamethasone dipropionate ointment is a high-potency corticosteroid indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13 years and older. betamethasone dipropionate ointment is contraindicated in patients who are hypersensitive to betamethasone dipropionate, to other corticosteroids, or to any ingredient in these preparations.